Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v2.4.0.6
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2013
Summary of Stock Options Available for Grant and Outstanding Options Activity

The following table summarises the Company’s shares available for grant as options, restricted stock units or other equity instruments under the LTIP and 2001 Equity Incentive Plan at 31 March 2013, 2012 and 2011:

 

     Shares
Available for
Grant
 

Balance at 31 March 2011

         26,588,283   
  

 

 

 

Granted

     (1,303,209

Forfeited

     -     

Forfeitures available for re-grant

     410,914   
  

 

 

 

Balance at 31 March 2012

     25,695,988   
  

 

 

 

Granted

     (1,415,605

Forfeited

     -     

Forfeitures available for re-grant

     223,400   
  

 

 

 

Balance at 31 March 2013

     24,503,783   
  

 

 

 

 

Stock Options

There were no stock options granted during the years ended 31 March 2013, 2012 and 2011. The following table summarises the Company’s stock options activity during the noted period:

 

     Outstanding Options  
     Number      Weighted
Average
Exercise
Price (A$)
 

Balance at 31 March 2011

         11,355,295           7.40   
  

 

 

    

Exercised

     (1,682,841)         6.25   

Forfeited

     (587,314)         7.76   

Forfeitures available for re-grant

     –        
  

 

 

    

Balance at 31 March 2012

     9,085,140           7.59   
  

 

 

    

Exercised

     (3,622,106)         7.01   

Forfeited

     (306,898)         8.56   

Forfeitures available for re-grant

     –        
  

 

 

    

Balance at 31 March 2013

     5,156,136           7.94   
  

 

 

    
Outstanding and Exercisable Options under 2001 Equity Incentive Plan and Long-Term Incentive Plan

The following table summarises outstanding and exercisable options under both the 2001 Equity Incentive Plan and the LTIP as of 31 March 2013:

 

Options Outstanding and Exercisable
Number           Weighted
Average
Remaining
Life (in Years)
     Weighted
Average
Exercise
Price (A$)
     Aggregate
Intrinsic
Value (A$)
       
  285,750           1.7         5.99         1,148,715      
  93,000           1.9         6.30         345,030      
  624,254           4.7         6.38         2,266,042      
  298,000           0.7         7.05         882,080      
  932,502           4.4         7.83         2,032,854      
  1,515,530           3.6         8.40         2,440,003      
  1,392,100           2.7         8.90         1,545,231      
  15,000           2.9         9.50         7,650      

 

 

        

 

 

  5,156,136           3.3         7.94             10,667,605      

 

 

        

 

 

 

Restricted Stock Activity

The following table summarises the Company’s restricted stock activity during the noted period:

 

     Shares          Weighted
Average Fair
Value at Grant
Date (US$)
 

Non-vested at 31 March 2011

     5,112,095           4.52   
  

 

 

      

Granted

     1,303,209           4.92   

Vested

     (2,527,601        3.13   

Forfeited

     (210,192        5.35   
  

 

 

      

Non-vested at 31 March 2012

     3,677,511           5.57   
  

 

 

      

Granted

     1,415,605           8.41   

Vested

     (846,415        7.13   

Forfeited

     (242,333        5.96   
  

 

 

      

Non-vested at 31 March 2013

     4,004,368           6.13   
  

 

 

      
Assumptions Used for Restricted Stock Grants

The following table includes the assumptions used for restricted stock grants (market condition) valued during the years ended 31 March 2013 and 2012:

 

Date of grant

     14 Sep 2012         15 Sep 2011   

Dividend yield (per annum)

     1.5%         2.0%   

Expected volatility

     52.2%         51.9%   

Risk free interest rate

     0.7%         1.0%   

Expected life in years

     3.0         3.0   

JHX stock price at grant date (A$)

     8.95         5.64   

Number of restricted stock units

     432,654         954,705